Escholarshipmetadata only
UC Comments in Response to FDA's Proposed Guidance for Sponsors, Investigators,and Institutional Review Boards on Key Information and Facilitating Understanding in Informed Consent (Docket Number: FDA-2022-D-2997)
comment letter, fda, irb, human subjects, consent
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 629288
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.